NEW YORK (GenomeWeb News) – Co-Diagnostics said recently that certain real-time PCR technology has been transferred to the company from DNA Logix.

DNA Logix transferred four patents and applications pursuant to a purchase agreement between the two firms. Under the terms of the agreement, Co-Diagnostics, based in Salt Lake City, exercised its option to purchase the technology related to real-time PCR diagnostics testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.